| |
Latest 10 SEC filings (by transaction date) for MGTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 12/24 | Forbes Alexandria | Direct Ownership | Ordinary Shares | G - Gift | -2,000 | |
Mar 4/24 | Feb 29/24 | Giroux Richard | Direct Ownership | Ordinary Shares | G - Gift | -13,500 | |
Jan 17/24 | Jan 17/24 | Giroux Richard | Direct Ownership | Restricted Share Units | A - Grant, award or other under Rule 16b-3(d) | 620,000 | |
Jan 17/24 | Jan 17/24 | Zeldin Robert K | Direct Ownership | Restricted Share Units | A - Grant, award or other under Rule 16b-3(d) | 70,000 | |
Jan 17/24 | Jan 17/24 | Zeldin Robert K | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Jan 17/24 | Jan 17/24 | Forbes Alexandria | Direct Ownership | Restricted Share Units | A - Grant, award or other under Rule 16b-3(d) | 620,000 | |
Jan 17/24 | Jan 17/24 | Naylor Stuart | Direct Ownership | Restricted Share Units | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Jan 17/24 | Jan 17/24 | Wollin Robert J | Direct Ownership | Restricted Share Units | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Jan 17/24 | Jan 14/24 | Giroux Richard | Direct Ownership | Restricted Share Units | M - Exercise or conversion exempt under rule 16b-3 | -25,000 | |
Jan 17/24 | Jan 14/24 | Giroux Richard | Direct Ownership | Ordinary Shares | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -13,219 | $6.36 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MGTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 12/24 | Forbes Alexandria | Direct Ownership | Ordinary Shares | G - Gift | -2,000 | |
Mar 4/24 | Feb 29/24 | Giroux Richard | Direct Ownership | Ordinary Shares | G - Gift | -13,500 | |
Jan 18/24 | Jan 7/24 | Zeldin Robert K | Direct Ownership | Ordinary Shares | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -13,773 | $6.30 |
Jan 17/24 | Jan 17/24 | Giroux Richard | Direct Ownership | Restricted Share Units | A - Grant, award or other under Rule 16b-3(d) | 620,000 | |
Jan 17/24 | Jan 14/24 | Giroux Richard | Direct Ownership | Restricted Share Units | M - Exercise or conversion exempt under rule 16b-3 | -25,000 | |
Jan 17/24 | Jan 14/24 | Giroux Richard | Direct Ownership | Ordinary Shares | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -13,219 | $6.36 |
Jan 17/24 | Jan 14/24 | Giroux Richard | Direct Ownership | Ordinary Shares | M - Exercise or conversion exempt under rule 16b-3 | 25,000 | |
Jan 17/24 | Jan 17/24 | Zeldin Robert K | Direct Ownership | Restricted Share Units | A - Grant, award or other under Rule 16b-3(d) | 70,000 | |
Jan 17/24 | Jan 17/24 | Zeldin Robert K | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Jan 17/24 | Jan 14/24 | Zeldin Robert K | Direct Ownership | Restricted Share Units | M - Exercise or conversion exempt under rule 16b-3 | -37,500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |